Cargando…
How to Maintain Safety and Maximize the Efficacy of Cardiopulmonary Resuscitation in COVID-19 Patients: Insights from the Recent Guidelines
Since December 2019, the novel coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has remained a challenge for governments and healthcare systems all around the globe. SARS-CoV-2 infection is associated with increased rates of hospital admissio...
Autores principales: | Chojecka, Dominika, Pytlos, Jakub, Zawadka, Mateusz, Andruszkiewicz, Paweł, Szarpak, Łukasz, Dzieciątkowski, Tomasz, Jaguszewski, Miłosz Jarosław, Filipiak, Krzysztof Jerzy, Gąsecka, Aleksandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658351/ https://www.ncbi.nlm.nih.gov/pubmed/34884368 http://dx.doi.org/10.3390/jcm10235667 |
Ejemplares similares
-
Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment
por: Skwarek, Aleksandra, et al.
Publicado: (2021) -
Correlation between takotsubo cardiomyopathy and SARS-CoV-2 infection
por: Szarpak, Lukasz, et al.
Publicado: (2021) -
Impact of COVID-19 pandemic on out-of-hospital cardiac arrest survival rate
por: Jaguszewski, Milosz Jaroslaw, et al.
Publicado: (2021) -
Efficacy and safety of levosimendan and dobutamine in heart failure: A systematic review and meta-analysis
por: Jaguszewski, Milosz J., et al.
Publicado: (2021) -
Meta-analysis of chest compression-only versus conventional cardiopulmonary resuscitation by bystanders for adult with out-of-hospital cardiac arrest
por: Bielski, Karol, et al.
Publicado: (2023)